Výsledky vyhledávání

In-vitro maturation versus IVF: a cost-effectiveness analysis

Autor: S.C. Braam, Lan N. Vuong, Toan D Pham, Vu N A Ho, Ben W.J. Mol, Madelon van Wely

Publikováno v: Reproductive biomedicine online, 42(1), 143-149. Elsevier

Research question How do costs and effects of in-vitro maturation (IVM) compare to IVF in women with a high antral follicle count (AFC)? Design This cost-effectiveness analysis (CEA) was based on data of a previous retrospective cohort study at IVFMD

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b2e872a05d913fb7a9f91e0e7285266
https://pubmed.ncbi.nlm.nih.gov/33132059

Zobrazit plný text záznamu

The perspective of women with an increased risk of OHSS regarding the safety and burden of IVF: a discrete choice experiment

Autor: Ben W.J. Mol, M. van Wely, S.C. Braam, J.P. de Bruin

Publikováno v: Human Reproduction Open

STUDY QUESTION What are the preferences of women with an increased risk of ovarian hyperstimulation syndrome (OHSS) for characteristics of IVF treatments? SUMMARY ANSWER In women with increased risk of OHSS, the chance of OHSS is a strong attribute i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67a05d3d0440af4591aa7939d03b5b74
https://pubmed.ncbi.nlm.nih.gov/32123754

Zobrazit plný text záznamu

The effectiveness and safety of in vitro maturation of oocytes versus in vitro fertilization in women with a high antral follicle count

Autor: Lan N. Vuong, S.C. Braam, Vu N A Ho, Ben W.J. Mol, Toan D Pham

Publikováno v: Human reproduction (Oxford, England), 34(6), 1055-1064. Oxford University Press

STUDY QUESTION: What is the effectiveness and safety of IVM compared with IVF for the treatment of women with high antral follicle count (AFC)? SUMMARY ANSWER: In women with high AFC undergoing assisted reproductive technique (ART), IVM is an effecti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18413e3e021b2780ee266b394c9da3db
https://pubmed.ncbi.nlm.nih.gov/31560747

Zobrazit plný text záznamu

Treatment strategies and cumulative live birth rates in WHO-II ovulation disorders

Autor: Erato T.I.A. Buisman, Jesper M. J. Smeenk, S.C. Braam, Carl J.C.M. Hamilton, M. Brandes, Jan Willem van der Steeg, Willianne L.D.M. Nelen, Ben W.J. Mol, Jan Bruin

Publikováno v: European Journal of Obstetrics & Gynecology and Reproductive Biology, 225, pp. 84-89
European journal of obstetrics, gynecology, and reproductive biology, 225, 84-89. Elsevier Ireland Ltd
European Journal of Obstetrics & Gynecology and Reproductive Biology, 225, 84-89

Objective To assess the live birth rate in women with WHO II anovulation and the proportion of women that need second or third line treatments if the initial therapy fails. Study design In this multicenter cohort study we included couples with unfulf

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34e6e619996fc91cf64eddd3f2136124
https://hdl.handle.net/2066/194589

Zobrazit plný text záznamu

Spontaneous pregnancies afterin vitromaturation treatment in two polycystic ovary syndrome patients

Autor: S.C. Braam, Jan Bruin, Ben W.J. Mol, Pettie H Maas, Anton A van Kamp

Publikováno v: Expert Review of Obstetrics & Gynecology. 7:119-122

Women with polycystic ovary syndrome who need IVF are at increased risk for ovarian hyperstimulation syndrome. Immature oocyte retrieval, and subsequent oocyte in vitro maturation (IVM), is an alternative that does not bear such a risk. We report two

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e6bfe7371e6d4b69965525f064dd978e
https://doi.org/10.1586/eog.12.5

Zobrazit plný text záznamu

Session 29: Ovarian stimulation

Publikováno v: Human Reproduction. 28:i44-i46

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bb866d819de94b6dcc6b2b3cbb718774
https://doi.org/10.1093/humrep/det157

Zobrazit plný text záznamu

SESSION 18: OHSS

Publikováno v: Human Reproduction. 27:ii26-ii28

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::490e26c99a0b0042170152ea7bc1f30f
https://doi.org/10.1093/humrep/27.s2.18

Zobrazit plný text záznamu

How long should we continue clomiphene citrate in anovulatory women?

Autor: Nienke S. Weiss, T.E. König, M. van Wely, Jesper M. J. Smeenk, C.A.M. Koks, B.W.J. Mol, C.B. Lambalk, M.L. Hendriks, Carl J.C.M. Hamilton, Eugenie M. Kaaijk, F. van der Veen, P.G.A. Hompes, S.C. Braam

Publikováno v: Human reproduction (Oxford, England), 29(11), 2482-2486. Oxford University Press
Weiss, N S, Braam, S, König, T E, Hendriks, M L, Hamilton, C J, Smeenk, J M J, Koks, C A M, Kaaijk, E M, Hompes, P G A, Lambalk, C B, van der Veen, F, Mol, B W J & van Wely, M 2014, ' How long should we continue clomiphene citrate in anovulatory women? ', Human Reproduction, vol. 29, no. 11, pp. 2482-2486 . https://doi.org/10.1093/humrep/deu215
Human Reproduction, 29(11), 2482-2486. Oxford University Press

study question: What is the effectiveness of continued treatment with clomiphene citrate (CC) in women with World Health Organization (WHO) type II anovulation who have had at least six ovulatory cycles with CC but did not conceive? summaryanswer: Wh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f68c14334a5d771091671aff4359f5ab
https://pure.amc.nl/en/publications/how-long-should-we-continue-clomiphene-citrate-in-anovulatory-women(fad9a2e6-c044-4c27-88e5-d0a13d222773).html

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání